Snowball logo
logo
6661

Welgene Biotech Co.Ltd.

6661 TWO
NT$16.80NT$0.00  (0%)
Estimate
EPS
-0.01
Beta
0.197
Growth
Revenue, YoY
7.54%
Net income, YoY
-37.61%
FCF, YoY
-596.79%
About the company
Ticker
6661
ISIN
Country
Taiwan
Sector (GICS)
Healthcare
Welgene Biotech Co.,Ltd. engages in the trade of biotechnology-related instruments, reagents, and biotechnology testing services. The company offers research services, including generation, PacBio third generation sequencing; microarray, protein body analysis; nucleic acid extraction/QC, single cell experimental, and bioinformatics analysis services. It also provides reagents, medical consumables, and instruments, as well as software services. Welgene Biotech Co.,Ltd. was founded in 2003 and is based in Taipei City, Taiwan.

Frequently asked questions

What sector does Welgene Biotech Co.Ltd. (6661) operate in?

Welgene Biotech Co.Ltd. belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is Welgene Biotech Co.Ltd. (6661) current stock price?

As of the latest data, Welgene Biotech Co.Ltd. stock price is NT$16.80, with a previous close of NT$16.80.

What is Welgene Biotech Co.Ltd. (6661) current market capitalization?

Welgene Biotech Co.Ltd. market cap is approximately 391.51 million.

What is Welgene Biotech Co.Ltd. (6661) Earnings Per Share (EPS)?

The trailing EPS is -NT$0.01.

Does Welgene Biotech Co.Ltd. (6661) pay dividends?

No. Welgene Biotech Co.Ltd. does not pay a dividend.

What is Welgene Biotech Co.Ltd. (6661) beta (volatility) score?

Welgene Biotech Co.Ltd. has a beta of 0.197, indicating lower volatility than the overall market.